January 2019 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for January 2019. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Rising Temps May Up Burden of Congenital Heart Disease in U.S.

THURSDAY, Jan. 31, 2019 (HealthDay News) — Projected increases in maternal heat exposure may result in increased congenital heart defect (CHD) burden, according to a study published online Jan. 30 in the Journal of the American Heart Association.

Abstract/Full Text

FDA Approves First Generic Version of Advair for Asthma, COPD

THURSDAY, Jan. 31, 2019 (HealthDay News) — The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the U.S. Food and Drug Administration.

More Information

More High-Value Care Associated With Receipt of Primary Care

THURSDAY, Jan. 31, 2019 (HealthDay News) — Receipt of primary care is associated with significantly more high-value care, slightly more low-value care, and a better health care experience, according to a study published online Jan. 28 in JAMA Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial

FDA Receives an ‘F’ in Tobacco Prevention Report Card

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The U.S. Food and Drug Administration was given an “F” in a new American Lung Association report card evaluating tobacco prevention programs.

CNN Article
State of Tobacco Control

Expanded Recall Announced for Ibuprofen Oral Suspension Drops

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — An expanded recall of ibuprofen oral suspension drops that may contain higher-than-specified levels of ibuprofen that could harm infants’ kidneys has been announced by Tris Pharma, Inc.

More Information

More Severe Injuries Sustained at Jump Parks Versus Home Trampolines

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The proportion of fractures/dislocations, lower-extremity fractures, fractures in adults, and surgical interventions is higher for injuries associated with jump parks versus home trampolines, according to a study published in the Jan. 1 issue of the Journal of the American Academy of Orthopaedic Surgeons.

Abstract/Full Text (subscription or payment may be required)

No Asthma Benefit Seen With n3PUFA in Overweight Teens

WEDNESDAY, Jan. 30, 2019 (HealthDay News) — Omega-3 fatty acid (n3PUFA) supplements do not appear to improve asthma control in teens and young adults who are overweight or obese, according to a study published online Jan. 25 in the Annals of the American Thoracic Society.

Abstract/Full Text (subscription or payment may be required)

1976 to 2016 Saw Drop in Firearm Ownership in Families

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13
Page 1 of 13
Next »